UnitedHealth Group Reports Strong Q2 Results and AI Investments

UnitedHealth Group outperforms Q2 expectations with strong earnings, guided by AI investments and improved medical care management. Learn more about their strategies.

Enhancing Healthcare Access for Rural Seniors Through Telehealth

Explore how telehealth and community resources improve healthcare access for rural seniors, ensuring quality care is within reach for all.

Changes to Private Health Insurance Rebates Impacting Older Australians

Explore the potential changes to private health insurance rebates and their effects on older Australians' healthcare access and security.

Impact of Capital Gains on Medicare Premiums: Understanding IRMAA

Learn how capital gains affect Medicare premiums through IRMAA and tips to minimize surcharges for retirees with stock sales.

Medicare Cost Adjustments in 2026: Understanding the Changes

Discover key 2026 cost adjustments for Medicare. Learn how new premiums and deductibles affect beneficiaries and explore financial strategies to manage expenses.

Understanding Medicare and Long-Term Care Planning

Explore Medicare's coverage gaps regarding long-term custodial care and the importance of early planning to mitigate financial burdens for dementia patients.

Medicare Finalizes LCD for CareDx's Molecular Tests Impacting Reimbursement

CareDx's molecular tests secure Medicare reimbursement clarity. Discover the new LCD's impact on transplant monitoring and investor strategy.

Medicare Expands Telehealth Services: A Guide for Insurance Professionals

Discover how Medicare's telehealth coverage enhances access for beneficiaries and what it means for insurance professionals ensuring compliance and customer service.

Contact Blue Cross and Blue Shield NC for Assistance

Get assistance from Blue Cross and Blue Shield of North Carolina for plan details, billing, and coverage inquiries. Call for support today!

Smith & Nephew's Lobbying Activities in 2026: Focus on Medicare and Security

Smith & Nephew Inc. reports $490,000 lobbying expense focusing on Medicare and healthcare issues. Insight into investor trends included.